摘要
目的:临床药师通过参与房颤合并冠心病经皮冠状动脉介入治疗(PCI)术后患者抗凝治疗的药学实践,优化选择有利于患者药物治疗的方案。方法:临床药师根据患者病情变化,从疾病及药物相互作用等多方面因素进行分析,提供咨询意见,与临床医师协商,制定个体化的治疗方案并随时调整。结果:经过反复调整华法林剂量以及其他治疗药物,并进行详细的患者教育,最终达到满意的抗凝治疗效果。结论:临床药师参与临床治疗实践,有利于制定个体化给药方案,有利于提高患者用药依从性,更好地保障用药的有效性和安全性。
Objective： To optimize the therapeutic regimen by clinical pharmacist participating in the anticoagulatJon regimen design for a patient with atrial fibrillation after PCI for coronary heart disease. Methods： Based on the disease progress, clinical pharmacist analyzed drug-drug interactions and other influence factors, provided advice, and consulted with clinicians to develop personalized treatment programs. Results： The patient ultimately achieved satisfactory anticoagulation effect by adjusting the warfarin dose and other medications, and accepting detailed patient education. Conclusion： Pharmaceutical care provided by clinical pharmacist is conducive to developing individualized dosage regimen, improving patients medication compliance, and guaranteeing the efficacy and safety of the medication.
出处
《临床药物治疗杂志》
2014年第4期57-60,共4页
Clinical Medication Journal
关键词
华法林
抗凝
房颤
冠心病
临床药师
warfarin
anticoagulation
atrial fibrillation
clinical pharmacist
